Insulin-like growth factor-1 genotypes and haplotypes influence the survival of prostate cancer patients with bone metastasis at initial diagnosis

被引：0
作者：
Norihiko Tsuchiya
Shintaro Narita
Takamitsu Inoue
Mitsuru Saito
Kazuyuki Numakura
Mingguo Huang
Shingo Hatakeyama
Shigeru Satoh
Seiichi Saito
Chikara Ohyama
Yoichi Arai
Osamu Ogawa
Tomonori Habuchi
机构：
[1] Akita University Graduate School of Medicine,Department of Urology
[2] Hirosaki University Graduate School of Medicine,Department of Urology
[3] University of the Ryukyu,Division of Urology, Department of Organ
[4] Tohoku University Graduate School of Medicine,oriented Medicine
[5] Kyoto University,Department of Urology
来源：
BMC Cancer | / 13卷
关键词：
Prostate cancer; Bone metastasis; Survival; Polymorphism; Insulin-like growth factor-1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Insulin-Like Growth Factor-1 Receptor Expression in Thymic Malignancies
    Girard, Nicolas
    Teruya-Feldstein, Julie
    Payabyab, Eden C.
    Riely, Gregory J.
    Rusch, Valerie W.
    Kris, Mark G.
    Zakowski, Maureen F.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (09) : 1439 - 1446
  • [22] Insulin-like growth factor-1 receptor expression in upper tract urothelial carcinoma
    Eich, Marie-Lisa
    Tregnago, Aline C.
    Faraj, Sheila F.
    Palsgrove, Doreen N.
    Fujita, Kazutoshi
    Bezerra, Stephania M.
    Munari, Enrico
    Sharma, Rajni
    Chaux, Alcides
    Netto, George J.
    VIRCHOWS ARCHIV, 2019, 474 (01) : 21 - 27
  • [23] Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA era
    Elizabeth A. Platz
    Michael N. Pollak
    Michael F. Leitzmann
    Meir J. Stampfer
    Walter C. Willett
    Edward Giovannucci
    Cancer Causes & Control, 2005, 16 : 255 - 262
  • [24] Plasma levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in women with cervical neoplasia
    Lee, Si Won
    Lee, Soo Yoon
    Lee, Sa Ra
    Ju, Woong
    Kim, Seung Cheol
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2010, 21 (03) : 174 - 180
  • [25] Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA era
    Platz, EA
    Pollak, MN
    Leitzmann, MF
    Stampfer, MJ
    Willett, WC
    Giovannucci, E
    CANCER CAUSES & CONTROL, 2005, 16 (03) : 255 - 262
  • [26] No Association of Insulin-like Growth Factor Gene Polymorphisms with Survival in Patients with Colorectal Cancer
    Cho, Yoon Young
    Kim, Jong Gwang
    Chae, Yee Soo
    Sohn, Sang Kyun
    Kang, Byung Woog
    Moon, Joon Ho
    Jeon, Seong Woo
    Park, Jun Seok
    Park, Jin Young
    Choi, Gyu Seog
    CANCER RESEARCH AND TREATMENT, 2011, 43 (03): : 189 - 194
  • [27] Insulin-Like Growth Factor-1 Influences Prostate Cancer Cell Growth and Invasion through an Integrin α3, α5, αV, and β1 Dependent Mechanism
    Siech, Carolin
    Rutz, Jochen
    Maxeiner, Sebastian
    Grein, Timothy
    Sonnenburg, Marlon
    Tsaur, Igor
    Chun, Felix K. -H.
    Blaheta, Roman A.
    CANCERS, 2022, 14 (02)
  • [28] Influence of polymorphisms in insulin-like growth factor-1 on the risk of osteoporosis in a Chinese postmenopausal female population
    Li, Feng
    Xing, Wen-Hua
    Yang, Xue-Jun
    Jiang, Hai-Yan
    Xia, Hong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (05): : 5727 - 5732
  • [29] Insulin-like growth factor 1 receptor affects the survival of primary prostate cancer patients depending on TMPRSS2-ERG status
    Caterina Mancarella
    Irene Casanova-Salas
    Ana Calatrava
    Maria García-Flores
    Cecilia Garofalo
    Andrea Grilli
    José Rubio-Briones
    Katia Scotlandi
    José Antonio López-Guerrero
    BMC Cancer, 17
  • [30] Insulin-like growth factor 1 receptor affects the survival of primary prostate cancer patients depending on TMPRSS2-ERG status
    Mancarella, Caterina
    Casanova-Salas, Irene
    Calatrava, Ana
    Garcia-Flores, Maria
    Garofalo, Cecilia
    Grilli, Andrea
    Rubio-Briones, Jose
    Scotlandi, Katia
    Antonio Lopez-Guerrero, Jose
    BMC CANCER, 2017, 17
12345